August 25, 2016 7:33 PM ET

Pharmaceuticals

Company Overview of Envoy Therapeutics, Inc.

Executive Profile

Brad A. Margus

Co-Founder, Chief Executive Officer and Director, Envoy Therapeutics, Inc.
AgeTotal Calculated CompensationThis person is connected to 5 Board Members in 5 different organizations across 6 different industries.

See Board Relationships
55--

Background

Mr. Brad A. Margus serves as Chief Executive Officer of Genome Bridge. Mr. Margus co-founded Envoy Therapeutics Inc., and served as its Chief Executive Officer From 2009 to 2012. Mr. Margus serves as a Community Advisor of Counsyl, Inc. He founded Exigence Neurosciences. He co-founded Perlegen Sciences, Inc. in 2000 and served as its Executive Vice Chairman since May 1, 2007, Chief Executive Officer from September 2000 to May 1, 2007 and its President since September, ...

Corporate Headquarters

555 Heritage Drive
Jupiter, Florida 33458

United States

Phone: 561-210-7705
Fax: --

Board Members Memberships

Co-Founder, Chief Executive Officer and Director
Director
Director
Board Member
2013-Present
Director

Education

MBA 1986
Harvard University
BA
The George Washington University

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Envoy Therapeutics, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.